A detailed history of Novo Holdings transactions in Insmed Inc stock. As of the latest transaction made, Novo Holdings holds 1,339,304 shares of INSM stock, worth $93.8 Million. This represents 2.95% of its overall portfolio holdings.

Number of Shares
1,339,304
Previous 1,339,304 -0.0%
Holding current value
$93.8 Million
Previous $41.5 Million 12.46%
% of portfolio
2.95%
Previous 3.49%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$16.26 - $21.73 $8.12 Million - $10.8 Million
499,304 Added 59.44%
1,339,304 $22.8 Million
Q4 2022

Feb 14, 2023

BUY
$16.98 - $23.15 $1.19 Million - $1.62 Million
70,000 Added 9.09%
840,000 $16.8 Million
Q2 2022

Aug 15, 2022

BUY
$17.07 - $25.71 $1.1 Million - $1.65 Million
64,162 Added 9.09%
770,000 $15.2 Million
Q1 2022

May 16, 2022

BUY
$20.42 - $28.13 $204,159 - $281,243
9,998 Added 1.44%
705,838 $16.6 Million
Q2 2021

Aug 16, 2021

BUY
$24.17 - $36.01 $5.78 Million - $8.61 Million
239,209 Added 52.39%
695,840 $19.8 Million
Q1 2021

May 17, 2021

BUY
$32.28 - $44.3 $856,194 - $1.18 Million
26,524 Added 6.17%
456,631 $15.6 Million
Q2 2020

Aug 14, 2020

BUY
$14.11 - $29.42 $6.07 Million - $12.7 Million
430,107 New
430,107 $11.8 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.49B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Novo Holdings Portfolio

Follow Novo Holdings and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

News

Stay updated on Novo Holdings with notifications on news.